Emergency IVF versus ovarian tissue cryopreservation decision making in fertility preservation for female cancer patients
This article examines emergency IVF and ovarian tissue storage and current data on their reproductive outcomes in cancer patients. These data challenge the concept that these techniques should be labeled “experimental.”
Karine Chung, M.D., M.S.C.E., Jacques Donnez, M.D., Elizabeth Ginsburg, M.D., Dror Meirow, M.D.
Volume 99, Issue 6, Pages 1534-1542, May 2013
Hundreds of thousands of women in their reproductive years are diagnosed with cancer each year. As the number of female patients who survive cancer increases, the demand for effective and individualized fertility preservation options grows. Currently there are limited clinical options for fertility preservation, and the paucity of publications describing clinical experience and outcomes data has limited accessibility to these options. Decision-making for patients diagnosed with cancer requires up-to-date knowledge of the efficacy and safety of available techniques. This article describes a step-by-step approach to evaluation of the cancer patient and presents an accumulation of clinical experience with challenges unique to patients with breast cancer and leukemia. Current data on reproductive outcomes of fertility preservation techniques are examined, demonstrating increasing evidence that these techniques are becoming efficacious enough to offer routinely to patients facing gonadotoxic cancer therapies, including those still considered “experimental.”